Revvity | PKI - Ebitda

Aktienkurs
86.77
Täglich Wechseln
-0.38 -0.44%
Monatlich
-1.22%
Jährlich
-7.98%
Q2 Prognose
84.91




Ebitda Veränderung Datum
Agilent USD 540M 74M 2025-09
Align Technology USD 183.84M 19.77M 2025-09
Bio Techne USD 103.42M 7.47M 2025-12
Bio-Rad Laboratories USD -374.6M 841.8M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Celltrion KRW 374.56B 352.67B 2025-09
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 135M 32M 2025-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Illumina USD 332M 12M 2025-09
Intuitive Surgical USD 1.09B 165.5M 2025-12
IQVIA Holdings USD 1.05B 97M 2025-12
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Laboratory Of America USD 588.1M 24.1M 2025-12
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Mesa Laboratories USD 9.58M 1.47M 2024-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Organigram Holdings CAD 5.26M 884K 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Pharma Mar EUR 44.96M 46.94M 2025-12
Qiagen NV USD 249.69M 56.53M 2025-12
Quest Diagnostics USD 557M 20M 2026-03
Quidel USD 153.3M 23.8M 2025-12
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Sartorius EUR 267.3M 10.1M 2026-03
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Tilray USD 8.36M 1.82M 2025-09
Waters USD 380.97M 85.83M 2025-12
Zealand Pharma A/S -727.47M 285.54M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M 2025-06